REQUEST A DEMO
Total
USD $0.00
Search more companies

Elixirpharm, S.R.O. (Slovakia)

Main Activities: Real Estate | Lessors of Other Real Estate Property
Secondary Activities: Pharmacies and Drug Stores
Full name: Elixirpharm, S.R.O. Profile Updated: July 28, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Elixirpharm, S.R.O. is based in Slovakia, with the head office in Spisska Nova Ves. It operates in the Real Estate sector. The company was established on September 09, 2009. In its most recent financial highlights, the company reported a net sales revenue increase of 16.41% in 2024. Its total assets grew by 150.45% over the same period. In 2024, Elixirpharm, S.R.O.’s net profit margin increased by 0.24%.

Headquarters
Zimna, 205/70
Spisska Nova Ves; Kosicky; Postal Code: 05201

Contact Details: Purchase the Elixirpharm, S.R.O. report to view the information.

Basic Information
Registered Capital:
Purchase the Elixirpharm, S.R.O. report to view the information.
Financial Auditors:
Purchase the Elixirpharm, S.R.O. report to view the information.
Incorporation Date:
September 09, 2009
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Elixirpharm, S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
16.41%
Total operating revenue
16.41%
Operating profit (EBIT)
45.89%
EBITDA
81.83%
Net Profit (Loss) for the Period
35.54%
Total assets
150.45%
Total equity
120.47%
Operating Profit Margin (ROS)
0.46%
Net Profit Margin
0.24%
Return on Equity (ROE)
-27.58%
Quick Ratio
-0.15%
Cash Ratio
0.13%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?